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A B S T R A C T
Leber inherited optic neuropathy (LHON) is characterized by subacute bilateral loss of central vision due to
dysfunction and loss of retinal ganglion cells (RGCs). Comprehensive visual electrophysiological investigations
(including pattern reversal visual evoked potentials, pattern electroretinography and the photopic negative
response) performed on 13 patients with acute and chronic LHON indicate early impairment of RGC cell body
function and severe axonal dysfunction. Temporal, spatial and chromatic psychophysical tests performed on 7
patients with acute LHON and 4 patients with chronic LHON suggest severe involvement or loss of the midget,
parasol and bistratified RGCs associated with all three principal visual pathways.
1. Introduction
Leber hereditary optic neuropathy (LHON) (OMIM 535000) is a
primary mitochondrial DNA (mtDNA) disorder that presents with bi-
lateral subacute loss of central vision (Nikoskelainen et al., 1996; Yu-
Wai-Man and Chinnery, 2013; Yu-Wai-Man et al., 2014). The majority
of patients harbour one of three common mtDNA mutations
(m.3460G > A in MTND1, m.11778G > A in MTND4 and
m.14484T > C in MTND6) that affect complex I subunits of the mi-
tochondrial respiratory chain (Mackey et al., 1996). Despite the uni-
versal cellular role of mitochondria, retinal ganglion cells (RGCs)
within the papillomacular bundle are particularly severely affected
accounting for the characteristic dense central or caecocentral scotoma
in this disorder. Although the underlying pathological process is still
not fully defined, this tissue specificity has been ascribed to an in-
creased vulnerability of RGCs to both disturbed mitochondrial energy
metabolism and the increased formation of reactive oxygen species
(Carelli et al., 2004a; Carelli et al., 2004b; Lin et al., 2012; Sadun et al.,
2000; Levin, 2015; Sadun et al., 2015). LHON shows maternal
inheritance, but there is variable disease penetrance and a marked sex
bias with about 50% of male carriers losing vision during their lifetime
compared with about 10% of female carriers (Mackey et al., 1996).
The histopathological observation of loss of the small calibre axons
that constitute the papillomacular bundle was originally observed on
histopathological sections of post mortem optic nerve samples obtained
several decades after disease onset (Sadun et al., 1994; Kerrison et al.,
1995; Sadun et al., 2000). More recently, in vivo studies involving high-
resolution optical coherence tomography (OCT) have revealed a major
loss of the temporal peripapillary nerve fiber (RNFL) and macular RGC
layers within 3 months of disease onset. Interestingly, pathological
thinning within the macular RGC layer was an early sign that was al-
ready apparent in the presymptomatic phase (Barboni et al., 2005;
Barboni et al., 2010; Akiyama et al., 2013; Zhang et al., 2014;
Mizoguchi et al., 2015; Balducci et al., 2015). Following disease con-
version, swelling of the peripapillary RNFL spreads circumferentially
from the inferotemporal segment of the optic disc to involve the re-
maining quadrants, before RNFL atrophy becomes established within
3–9 months after the onset of visual loss. Hyperemia and fluctuating
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mild swelling of the prepapillary RNFL can also be seen in unaffected
LHON carriers without visual loss or progression to full disease con-
version (Nikoskelainen et al., 1982).
The function of the papillomacular bundle may be assessed objec-
tively using pattern reversal visual evoked potentials (PR-VEP) and
pattern electroretinography (PERG). Reported PR-VEP abnormalities in
LHON are consistently severe, but the utility of the PERG in LHON is
more controversial and there are conflicting reports in the literature
regarding the timing of responses and the sequence of losses
(Nikoskelainen et al., 1977; Hrynchak and Spafford, 1994; Mashima
et al., 1997; Sharkawi et al., 2012; Ziccardi et al., 2013; Ziccardi et al.,
2015; Jarc-Vidmar et al., 2015). The full-field photopic negative re-
sponse (PhNR) has been used to assess generalized RGC function in
glaucoma and other acquired optic neuropathies (Machida, 2012;
Morny et al., 2015), but there are no published studies of PhNR in
LHON. The applicability of PhNR as a potential objective functional
index of RGC function in LHON therefore warrants further investiga-
tion.
RGCs are classified into the three major subtypes of RGCs, namely
midget, parasol and small bistratified ganglion cells, which are thought
to contribute to the parvocellular, magnocellular and koniocellular
pathways, respectively. These distinct RGC populations and their as-
sociated pathways can be tested by modifying standard psychophysical
measures. In general, the processing of high spatial frequency in-
formation has been linked with the parvocellular pathway whereas high
temporal frequency information is thought to be integrated by the
magnocellular pathway. Red-green processing and blue-yellow pro-
cessing have been linked with the parvocellular and koniocellular
pathways, respectively. Parallel processing in the retina and visual
pathways have been the subject of several recent comprehensive re-
views (e.g., Dowling, 1987; Wässle and Boycott, 1991; Rodieck, 1998;
Lennie and Movshon, 2005; Lee et al., 2010; Dacey et al., 2014).
LHON is thought to mainly affect midget RGCs, which have the
smallest calibre axons and are the predominant subtype within the
papillomacular bundle, mediating visual information including high
spatial frequencies and red-green chromaticity (Sadun et al., 1994;
Hrynchak and Spafford, 1994; Kerrison et al., 1995; Sadun et al., 2000).
In contrast, another melanopsin-expressing RGC subtype appears rela-
tively preserved and this peculiarity likely accounts for the frequently
preserved pupillary light reflexes, even in severely affected LHON pa-
tients (Kawasaki et al., 2010; La Morgia et al., 2010). One previous
report indicated mild impairment of the magnocellular pathway in
unaffected LHON carriers (Gualtieri et al., 2008), but there are no ro-
bust data regarding the involvement of the parasol and small bis-
tratified RCG subtypes in LHON.
In this study, we investigated the pattern of RGC dysfunction in a
well-phenotyped cohort of LHON patients in both the acute and chronic
phases of the disease by using a comprehensive visual electro-
physiological and psychophysical assessment protocol. Our aim was,
firstly, to characterise the electrophysiological responses to better de-
fine the phenotypic features of LHON and to establish the most ap-
propriate methods for monitoring RGC function and disease progression
objectively. Secondly, we used psychophysical tests of temporal, spatial
and chromatic vision to investigate the relative involvement of distinct
RGC populations in the pathophysiology of LHON.
2. Methods
2.1. Subjects
This was a prospective case study of 12 affected patients (A1–A12)
and 9 unaffected carriers (U1–U9) harboring one of the three common
mtDNA LHON mutations (Table 1). In addition, retrospective visual
electrophysiological data for 5 affected LHON patients (A13-A17) were
retrieved from the hospital database of Moorfields Eye Hospital,
London, UK. In total, there were 4 affected female and 13 affected male
patients. Affected LHON patients and unaffected LHON carriers in our
cohort underwent an ophthalmological examination that included the
following investigations as indicated in Table 1: best corrected visual
acuity (BCVA) assessment using the Early Treatment Diabetic Retino-
pathy Study (ETDRS) chart; slit lamp examination; automated Hum-
phrey visual field perimetry (Program 30-2, Humphrey Visual Field
Analyzer, Model 750, Humphrey Instruments, San Leonardo, CA); and
optical coherence tomography (OCT) imaging of the macula and the
optic nerve head (see details below).
The normal subjects for psychophysical tests were 15 individuals
aged 17 to 78 years old at the time of testing with normal BCVA and
normal color vision as assessed by standard color vision tests. Only 12
of the normal subjects had their L-cone temporal contrast sensitivities
measured. Written informed consent was obtained from all subjects or
their guardians. The study was approved by the local ethics committees
at Moorfields Eye Hospital and University College London and it con-
formed to the standards of the Declaration of Helsinki.
2.2. Optical coherence tomography (OCT) imaging
The Spectralis™ platform (Heidelberg Engineering Ltd., Heidelberg,
Germany) was used for SD-OCT imaging of the macula and the optic
nerve head. Automated segmentation and thickness analyses were
performed for perifoveal volumetric retinal B-scans using the
Heidelberg Engineering segmentation tool, included in the Spectralis
Glaucoma Module software (version 6.0). Of the 10 retinal layers that
were automatically defined and manually confirmed, the following
thickness values were recorded from the four sectors of the inner ring
(between 1 and 3 mm diameter) of the nine macular ETDRS subfields as
described elsewhere (Majander et al., 2016): (i) retina, (ii) retinal nerve
fiber layer (RNFL), (iii) combined GCL and inner plexiform layer (IPL),
(iv) inner nuclear layer (INL), (v) outer plexiform layer (OPL), (vi)
combined OPL and outer nuclear layer (ONL), and (v) inner retina. The
thickness of the outer retinal layers was calculated by subtracting the
thickness of the inner retinal layers from the total retinal thickness.
Normative data was generated from SD-OCT images of 48 healthy eyes
of 48 subjects (Majander et al., 2016). For peripapillary RNFL mea-
surement a 3.5-mm-diameter circular scan centered on the optic disc
was used and the data for six sectors were collected.
2.3. Electrophysiology investigations
Twelve subjects underwent electrophysiological testing including
pattern reversal and flash visual evoked potential (PVEP; FVEP) and
pattern electroretinography (PERG), incorporating the standards of the
International Society for Clinical Electrophysiology of Vision (ISCEV;
Odom et al., 2010, Bach et al., 2013). Pattern ERGs were recorded to a
0.8- degree check size using both a standard checkerboard field
(12 × 15°) and additionally to a large field (24 × 30°; LF PERG; Lenassi
et al., 2012). The full-field photopic negative response (PhNR) was
additionally recorded in 7 cases using diffuse red flash stimulation
(640 nm) at 5 flash strengths (0.5, 1.0, 2.0, 5.0 and 10.0 cd·s·m−2),
superimposed on a blue background (450 nm; 2.25 cd·m−2). Gold foil
electrodes were used and the results compared to normative data.
2.4. Psychophysical investigations
2.4.1. L- and S-cone critical flicker fusion and L-cone temporal contrast
sensitivity
L- and S-cone temporal acuities (critical flicker fusion, CFF) and L-
cone temporal contrast sensitivity functions (TCSFs) were measured
using a Maxwellian-view optical system described in more detail else-
where (Stockman et al., 2014a, 2005). Predominantly L-cone or S-cone
stimuli were used for the CFF measurements. The L-cone stimulus was
produced by flickering a 650-nm circular target of 4° visual angle in
diameter superimposed in the center of a steady 481-nm circular
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background field of 9° diameter. The background radiance was fixed at
8.3 log10 quanta s−1 deg−2 and the target radiance was varied in steps
from 6.5 to 10.5 log10 quanta s−1 deg−2. The S-cone stimulus was
produced by flickering a 440-nm circular target also of 4° diameter
superimposed in the center of a 620-nm circular background field of 9°
diameter. The 620-nm background radiance was fixed at 8.3 log10
quanta s−1 deg−2 and the 440-nm target radiance was varied in steps
from 6.5 to 10 log10 quanta s−1 deg−2. The 650-nm target and 481-nm
background were also used for the L-cone TCSF measurements with the
time-averaged mean radiance of the 650-nm target fixed at 10.6 log10
quanta s−1deg−2. Before each run the subjects were light-adapted to
the background and target for at least 2 min. The observers viewed the
stimuli monocularly with their preferred eye (see Table 1) and inter-
acted with the computer by means of an 8-button keypad. Each ex-
periment was repeated 2–3 times on the same day. The method of ad-
justment was used. In the CFF measurements, observers varied the
frequency of the 650 or 440-nm target, which was sinusoidally-flick-
ering with a contrast of 92%, to find the frequency at each target ra-
diance at which the flicker until the flicker just disappeared. In the
TCSF measurements, observers varied the contrast of the sinusoidally-
flickering 650-nm target to establish the contrast at each target fre-
quency at which the flicker disappeared. Details of these measurements
have been given elsewhere (Stockman et al., 2014a).
2.4.2. Achromatic spatial contrast sensitivity function (SCSF)
Achromatic spatial contrast sensitivity (SCSF) was measured as a
function of spatial frequency. The target stimuli were generated on a
gamma-corrected Sony Trinitron monitor (Model GDM F520) with a
resolution of 1600 × 1200 pixels and produced at a frame rate of 85-
Hz. The monitor was driven by a DataPixx video processor (VPixx
Technologies Inc., Saint-Bruno, QC, Canada). The full screen subtended
a visual angle of 39° × 29° at a test distance of 0.57 m. The experiments
were performed at a constant mean luminance of 44.57 cd/m2 as
measured by a ColorCal calibration device (Cambridge Research
Systems Ltd., Rochester, UK). The stimuli were horizontally-orientated
Gabor patterns with spatial frequencies ranging from 0.25 to 16 cycles
per degree (cpd) and with a spatial Gaussian window with a standard
deviation of 6°. The target was presented for 500 ms, preceded and
followed by 100 ms cosine-windowed onsets and offsets. The order of
presentation was from low to high spatial frequency. Thresholds were
measured using a staircase procedure. Observers indicated whether or
not they could detect the spatial variation in the Gabor pattern using a
2-button keypad.
Stimulus contrast was defined as (Lmax− Lmin) / (Lmax + Lmin),
where Lmax and Lmin are the maximum and minimum luminances in the
Gabor pattern, respectively. Contrast was adjusted according to a one-
up-one-down staircase procedure with a variable step-size. The step-
size was 0.3 log10 units for the first five reversals (changes in the di-
rection of the staircase), after which it was reduced to 0.2 log10 units for
two more reversals and then finally to 0.1 log10 unit for the last four
reversals. A single run required a total of 9 reversals, with the contrast
“threshold” taken as the average of the last six reversals. Contrast
sensitivity is the reciprocal of the contrast threshold. The SCSF mea-
surements lasted approximately 20 min for each observer. The stimuli
were viewed binocularly with natural pupils and appropriate correction
if needed.
2.4.3. Chromatic discrimination
Chromatic discrimination was tested using the so-called trivector
test procedure implemented as part of the Cambridge Color Test (CCT),
Table 1
Clinical characteristics of the recruited LHON cohort and the timing of investigations in relation to disease onset.
Subjects Age (Y) sex Genotype BCVA logMARa Visual field defect MD (dB) Time from LHON onset at study (months)
OCT Electrophysiology Psychophysics
RE LE RE LE RE LE RE LE RE/LE
Affected LHON patients
A1 42 M m.11778G > A 1.4 1.5a −32.26 −28.63a 15 15 16 16 9 LE
A2 18 M m.11778G > A 1.6 1.5a −32.07 −32.89a NP 18 18 10 LE
A3 19 F m.3460G > A 1.9a 1.9 −34.39a −34.46 0.7 0 17 16 10 RE
A4 21 M m.11778G > A 2.0 2.0a −34.18 −33.79a 15 19 15 19 9 LE
A5 17 M m.11778G > A 2.2a 2.28 −34.48a −34.31 10 10 14 15 10 RE
A6 15 M m.11778G > A 1.6a 1.7 −29.11a −28.56 6 6 8 8 6 RE
A7 22 M m.11778G > A 0.7 0.8a −19.36 −15.10a 32 32 NP 36 LE
A8 33 M m.11778G > A 2.1a 2.1 −33.30a −33.23 34 28 34 RE
A9 24 M m.14484T > C 1.3a 1.3 −12.01a −12.63 20 23 23 RE
A10 51 F m.11778G > A 1.6a 1.6 −24.23a −27.51 40 40 40 RE
A11 23 M m.11778G > A 1.8a 2.3 −32.11a −29.76 4 5 4 RE
A12 50 F m.11778G > A 1.9 1.9 −30.54 −29.86 6 0 10 3 NP
A13 22 M m.11778G > A 0.8 1.0 NP 0 1 0 1
A14 36 M m.14484T > C 1.3 1.0 98 98 5 5
A15 7 M m.11778G > A 0.6 2.0 140 140 27 27
A16 7 F m.3460G > A 1.7 1.5 NP 2 2
A17 59 M m.3700G > A 1.9 1.9 20 20
Unaffected LHON carriers
U1 44 F m.11778G > A 0a 0 −10.83a −18.08 P NP P
U2 46 M m.11778G > A 0a 0 −2.57a −2.42
U3 52 F m.3460G > A 0.1a 0 −0.97a −1.43
U4 47 F m.11778G > A −0.1a −0.1 −3.51a −3.17
U5 50 F m.14484T > C 0.1a 0 0.18a 0.26
U6 50 F m.11778G > A −0.1a 0.1 −2.59a −0.24
U7 41 F m.3460G > A 0a 0 0.06a −0.99
U8 60 F m.3460G > A −0.1a 0 1.11a 0.22
U9 46 F m.11778G > A 0a 0 −1.81a −1.64
Abbreviations: BCVA, best corrected visual acuity: DOA, dominant optic atrophy; F, female; LE, left eye; LHON, Leber hereditary optic atrophy; M, male; NP, not performed; P, performed;
RE, right eye.
a BCVA and MD of the eye used for the monocular psychophysics tests are indicated by asterisks.
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v1.5, (Cambridge Research Systems Ltd., Rochester, UK). The test was
performed using a second gamma-corrected Sony FD Trinitron color
monitor (Model GDM-F500R) connected to a VSG 2/5 visual stimulus
generator (Cambridge Research Systems, Rochester, UK) with 800 by
600 pixel resolution. The CRT phosphors measured in CIE 1976 u′, v′
chromaticity coordinates (or CIE 1931 x, y coordinates) using ColorCal
photometer (Cambridge Research System) were: red phosphor (R)
u′ = 0.416; v′ = 0.522 (x = 0.610, y = 0.340); green phosphor (G)
u′ = 0.117; v′ = 0.559 (x = 0.280, y = 0.595); blue phosphor (B)
u′ = 0.159; v′ = 0.177 (x = 0.142, y = 0.070). The visual stimuli
consisted of Landolt “C” targets that varied in orientation presented on
a background of neutral chromaticity (CIE 1976 coordinates
u′ = 0.1977, v′ = 0.4689). The background and the target were made
up of small disks of variable size and luminance (ten equal steps be-
tween 8.0 and 18.0 cd·m2). The circles making up the Landolt C were
varied in chromaticity to find the threshold for correctly discriminating
the orientation of the Landolt C. The chromaticity was varied separately
along the three color directions that are invisible to observers lacking
L-, M- or S-cones; that is, the protan, deutan and tritan vector direc-
tions, respectively.
The test conditions were modified for observers with reduced visual
acuity. Instead of the viewing distance being set so that the Landolt “C”
opening subtended 1° of visual angle, the viewing distance was reduced
to 62.6 cm so that the opening subtended 5° of visual angle. Two (A7,
A9) of the 11 affected LHON carriers, and one patient A6 after spon-
taneous recovery, were able to perform the CCT test at this viewing
distance. Another 5 patients were able to perform the test at a viewing
distance of 5 to 10 cm that enabled recognition of the orientation of the
gap despite their central scotomatas. Thresholds were measured along
the protan, deutan, and tritan confusion lines. The upper limit for target
saturation was increased to 1600 × 10−4 u′v′ units and the number of
steps increased from 6 to 10 in order to maintain the standard unit
difference between the steps. The time allowed for each subject to re-
spond was increased from the standard 8 s to 20 s. The test was then run
using a standard descending psychophysical staircase procedure with
six reversals. Observers were instructed to respond to the gap position
(four-alternative forced choice) by means of a 4-button keypad. The test
was performed binocularly with appropriate near corrections if needed.
Six of the affected LHON carriers repeated the CCT test 6 to 12 months
after their first visit.
2.5. Statistical analyses
Mann-Whitney U independent samples test was used for comparison
of distribution of continuous variables in LHON and normal observers.
Spearman's rank correlation test was used for the analysis of statistical
dependence between the variables.
3. Results
3.1. The acute phase of LHON is characterized by rapid loss of RGCs
Macular SD-OCT revealed selective loss of the GCL-IPL complex
thickness (50% of the normal) within the first few months of disease
onset in LHON as shown in the Supplementary Table S1 and Fig. 1. This
occurred in parallel with loss of the temporal peripapillary RNFL
thickness (Spearman rho= 0.628, p = 0.002), whereas progression of
RNFL thinning in the nasal sectors was less steep. The INL was slightly,
but significantly thicker in the affected LHON carriers compared with
controls or the unaffected LHON carriers.
3.2. Visual electrophysiology: pattern responses were more severely affected
than photopic negative ERG responses
The age of the patients at the time of electrophysiological testing
ranged from 7.5 to 59.0 years (mean = 26.6 years; SD = 16.7 years).
The duration of symptoms ranged from 0 to 27 months (mean
12.5 months). Visual acuity was severely impaired in all cases
(range = 1.3 logMAR to perception of light). Characteristic electro-
physiology waveforms for affected LHON carriers are shown in Fig. 2.
Photopic negative responses were attenuated at all stimulus strengths
(see corresponding plots in Fig. 2c and d; orange circles). Pattern re-
versal VEPs were undetectable and flash VEPs were grossly abnormal.
Pattern ERG P50 is of short peak time and the waveforms had a low
N95:P50 ratio, in keeping with severe optic nerve/retinal ganglion cell
dysfunction bilaterally.
Pattern reversal VEPs were undetectable in 20 of 24 eyes and were
delayed in 4 eyes of 4 subjects with detectable responses (peak time
121-142 ms; upper limit of normal 115 ms); amplitudes in 2 of the eyes
with a delayed VEP were within the normal range (> 4 μV). Flash VEPs
were undetectable in 5 eyes of 3 subjects (all with undetectable pattern
VEP), were delayed (P2 > 140 ms) in 5 eyes, and were present but
subnormal (< 5 μV) in 20 eyes. Flash VEPs were normal in 3 eyes of 2
subjects including one of the youngest individuals (age 7.5 years). The
severity of pattern and flash VEP abnormality did not significantly
correlate either with age or duration of symptoms.
Pattern ERG P50 to a standard stimulus (field size 12° × 15°) was of
abnormally short peak time (< 45.5 ms) in 19 of 21 eyes (Fig. 3a
PERG). P50 was of normal amplitude in most, mildly subnormal
(< 2.0 μV) in 4 eyes of 4 patients (1.5–1.9 μV) and of borderline am-
plitude (2.0 μV) in a further 2 eyes (Fig. 3b PERG); P50 was of shor-
tened peak time in all 6 eyes with a borderline or mildly subnormal
amplitude. The N95:P50 amplitude ratio was subnormal (< 1.1) in 17
of 19 eyes (0.75–1.0) and at the lower limit of normal (ratio = 1.1) in a
further 2 eyes (mean and median ratio of all cases 1.0; SD 0.1; Fig. 3c
PERG). PERGs were technically poor in 5 eyes of 4 cases due to variable
fixation (N = 1); pupil dilation (N = 1) or physiological noise and
those eyes were excluded from analysis. PERG to a doubled stimulus
field (24° × 30°) were obtained in 11 patients including 4 eyes in which
the standard field PERG was excluded. Data were compared with a
normative data set obtained using the same large field stimulus. Sixteen
of 22 eyes were of abnormally short peak time (< 46.5 ms; Fig. 3d
PERG) and these included 4 patients with additional bilateral P50 re-
duction (1.9 μV–2.7 μV; normal > 3.9 μV). The N95:P50 ratio was
Fig. 1. Optical coherence tomography data. Macular ganglion cell – inner plexiform layer
complex (GCL-IPL) and peripapillary retinal nerve fiber layer (RNFL) thicknesses of 22
eyes have been presented as percentages of the normal mean and plotted as a function of
time from LHON onset in each eye. The data have been shown for temporal (T), nasal (N)
and combined supero- and inferotemporal (TS and TI) sectors of peripapillary RNFL.
Generalized additive model (GAM) fits to data are indicated by the color coded lines. (For
interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.)
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subnormal in 8, borderline in 10 and normal in 5 eyes (Fig. 3e PERG).
There was no significant correlation between pattern ERG parameters
and age or duration of symptoms.
International-standard full-field ERGs revealed no clinically sig-
nificant abnormality in the 7 individuals tested. PhNRs were recorded
from 14 eyes of 7 cases, including 5 individuals that did not undergo
standard full-field ERGs. The ratios of PhNR/b-wave ratios were within
the normal range in 1 eye at all 5 flash intensities; in others the ratio
was subnormal to one flash strength (N = 2 eyes), two (N = 3 eyes),
three (N = 1 eye), four (N = 4 eyes) or 5 flash strengths (N = 3 eyes)
(Fig. 4 PhNR). The mean magnitude of reduction of subnormal
responses was 13% (range 1.5–23%) compared with the lower limit
of normal. Forty percent of responses showed no abnormality (Fig. 4c
and d).
Fig. 2. Photopic negative responses from the right (a) and left (b) eyes of a patient with LHON (A3). For comparison, representative normal recordings over a range of flash strengths
(0.5–10.0 unit) have been provided (c). Pattern reversal VEPs, flash VEPs and pattern ERGs are shown for the right (d) and left (e) eyes of Patient A3 compared with representative normal
recordings (f). The patient's recordings have been superimposed for all the parameters tested to demonstrate reproducibility.
Fig. 3. Pattern ERG data. Pattern ERG parameters were obtained to a standard (12° × 15°; a–c) and large (24 × 30°; d–f) checkerboard stimulus field for right and left eyes (RE; LE).
Broken lines show the limits of normality defined as the minimum/maximum amplitude or peak time in a healthy cohort of subjects +/− the reference interval (maximum normal value-
minimum normal value). Pattern ERG peak times and/or the N95:P50 ratio were abnormal in all the cases. Large field pattern ERG parameters were abnormal in most cases, including
those in which PERG to the smaller field was excluded. The P50 amplitude of the pattern ERG was normal or near-normal in most cases, indicating good fixation despite of poor visual
acuity.
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3.3. Visual psychophysics
3.3.1. L-cone temporal functions were severely compromised in LHON
The data for L-cone cff (temporal acuity) are presented in Fig. 5 and
are summarized in the Supplementary Table S2. In the normal ob-
servers (grey triangles), flicker was first seen at a target radiance of 6.6
log10 quanta s−1 deg−2. The cff then grew linearly with log radiance
over about 3 log10 units with a slope of 9.2 Hz per log10 unit (see upper
blue line in the lower panel) until reaching a plateau near 40 Hz
(Stockman et al., 2014a). The linear relationship between cff and log
radiance is known as the Ferry-Porter law (Ferry, 1892; Porter, 1902).
Eight of the 11 affected LHON carriers were able to detect L-cone
flicker, but the mean radiance of 9.6 log10 quanta s−1 deg−2 at which
flicker was first seen was 30 times higher than that for normal observers
(Table S2). Three patients could detect flicker only at the highest target
radiances. LHON patients thus required higher radiances to detect
flicker than normal subjects and their cffs showed severe losses
reaching a mean plateau of only 12 Hz, 28 Hz less than normal subjects.
The lowest radiance at which unaffected LHON carriers first detected
flicker was slightly higher than that for normal subjects (Table S2).
Three carriers (U2, U6, U9) had significantly shallower Ferry-Porter
slopes than normal and only three carriers (U1, U4, U8) had cffs that
reached the normal plateau level of 40 Hz. The majority of the LHON
carriers showed some loss of cff. Patient A6 experienced spontaneous
recovery of BCVA from 1.6 logMAR to 0.1 logMAR between 6 and
18 months after LHON onset. His cff improved, but only marginally (A6
F, yellow squares).
Fig. 6 shows the L-cone temporal contrast sensitivity data. The mean
L-cone TCSF for normal subjects peaks in sensitivity near 8 Hz and falls
off in sensitivity at both low and high temporal frequencies (Stockman
et al., 2014a, 2014b; Ripamonti et al., 2014). Only patients A3, A7 and
A9 of the affected carriers were able to perform the test and showed a
mean sensitivity loss of 1.0 log10 unit. Unaffected LHON carriers had
normal L-cone temporal modulation sensitivities but were unable to
make settings at the highest temporal frequencies, consistent with their
lower cffs.
3.3.2. S-cone temporal function was unmeasurable in most LHON patients
and reduced in the unaffected m.3460G > A carriers
In the normal subjects, flicker was first seen at a target radiance of
about 6.5 log10 quanta s−1 deg−2. Thereafter, the cff grows linearly
with log radiance with a slope of 7.3 Hz per log10 unit, consistent with
the Ferry-Porter law, until reaching a plateau at 9.0 log10 quan-
ta s−1 deg−2 (see Fig. 7 and the Supplementary Table S3). The rise
after 9.9 log10 quanta s−1 deg−2 is due to M-cone intrusion - the M-
cones become more sensitive than S-cones at high radiances and thus
mediate flicker detection (Stockman and Plummer, 1998; Stockman
et al., 2014a).
Only two affected LHON carriers (A7, A9) were able to detect any
440-nm flicker, and all showed severely impaired temporal acuity. S-
cone cff was relatively normal for the unaffected carriers of the m.
11778G > A and the m. 14484T > C mutations, who first saw flicker
at 07.10 ± 0.06 (mean ± 1 SEM) log10 quanta s−1 deg−2, and ex-
hibited a Ferry-Porter slope of 7.97 ± 0.39 Hz per decade (mean ± 1
SEM) and a cff plateau frequency of 22.94 ± 0.57 Hz (mean ± 1
SEM). In contrast, S-cone cff for the three carriers harboring the
m.3460G > A mutation was compromised: those subjects first saw
flicker at a radiance of 8.06 ± 0.51 log10 quanta s−1 deg−2, and ex-
hibited a shallow Ferry-Porter slope of 5.03 ± 1.05 Hz per log10 unit,
the cff reached a plateau frequency of 12.61 ± 3.80 Hz. One carrier of
Fig. 4. Photopic negative response (PhNR) data. Mean photopic negative responses (a) and the mean PhNR/b-wave ratio (b) were recorded in 7 individuals with LHON and compared
with normal values at 5 flash strengths. The solid line and error bars show the mean normal values and 2 standard deviations from the mean. Broken lines show the limits of normality
defined as the minimum amplitude in the normal cohort minus the 5% of the reference interval (maximum normal value-minimum normal value). Ratios from each individual are shown
for right (RE; c) and left (LE; d) eyes. Sixty percent of responses were just outside the limits of normality (see text for details).
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the three with the m.3460G > A mutation could detect flicker only at
the highest radiances, but was within normal limits for the tritan
measurements in the CCT (see below).
3.3.3. Achromatic spatial contrast sensitivity function (SCSF) was
unmeasurable in most LHON patients and mildly subnormal in the
unaffected carriers
The mean achromatic spatial contrast sensitivity function for
normal subjects is shown as inverted grey triangles in each of the three
panels of Supplementary Fig. S1. The function is band-pass in shape
peaking at 2 cpd and falling off in sensitivity at lower and higher spatial
frequencies characteristic of other SCSFs measured at moderate and
high intensities (Robson, 1966; van Nes and Bouman, 1967). Only two
(A7 and A9) of the 11 affected LHON carriers could perform this test.
Both patients showed a loss of contrast sensitivity that increased with
frequency. In the unaffected LHON carriers, the achromatic SCSF was
normal at the lowest spatial frequency but showed increasing loss as
spatial frequency increased.
3.3.4. Chromatic discrimination was severely affected in LHON
Fig. 8A shows the vector lengths of the three confusion lines
(protan, deutan, and tritan) of the Cambridge Color Test in 10−4 u′v′
units (the CIE 1976 u′v′ color space). The longer the vector length the
more saturated the color had to be for the orientation of the gap in the
Landolt C to be discriminated. The maximum vector lengths were 1600
10−4 u′v′ units (the CIE 1976 u′v′ color space). The vector lengths in
the normal observers were comparable to those previously reported
using standard targets with 1° gaps: 45.1 ± 1.0 for protan, 43.3 ± 0.8
for deutan and 51.5 ± 1.3 for tritan in 10−4 u′v′ units (the CIE 1976
u′v′ color space) [mean ± SEM] (Paramei and Oakley, 2014). Alto-
gether, 8 affected LHON carriers could discriminate the gap in the
Landolt C, most viewed the CRT screen from only 5 to 10 cm Their
vector thresholds along the protan and the deutan axes on their first
tests were 25.8 ± 2.6 (mean ± SEM) and 25.4 ± 2.8 times higher,
respectively, than controls whereas along the tritan axes the vectors
were only 5.1 ± 0.7 times higher. Fig. 8B shows the vector lengths of
the successive tests made on six affected LHON carriers. Three affected
carriers (A1, A3, A6), initially studied 6 to 9 months after LHON onset,
showed recovery of color discrimination, mainly along protan and
deutan axes. Chromatic discrimination in unaffected LHON carriers was
only marginally subnormal along all chromatic axes with high normal
vector lengths. Affected observers therefore show a general loss along
all three axes.
4. Discussion
Our comprehensive electrophysiological and psychophysical study
of patients with acute and chronic LHON highlights the marked extent
of RGC dysfunction in this classical mitochondrial optic neuropathy.
Our study also indicates the utility of the standard transient pattern
ERG technique in patients with LHON, with the recordings revealing
severe central RGC dysfunction in all the patients tested, irrespective of
visual acuity, age or the duration of symptoms. Detailed psychophysical
data demonstrated loss of visual function in affected LHON carriers
across a range of parameters, including achromatic spatial and L-cone
temporal contrast sensitivity, L- and S-cone acuity, and chromatic dis-
crimination. These findings are consistent with substantial losses of the
principal RGC subtypes associated with each of the three major retinal
pathways. Furthermore, with the exception of L-cone TCSF, unaffected
LHON carriers also showed subclinical abnormalities in all the psy-
chophysical measures that were evaluated.
A number of studies have reported abnormal cortical PR-VEPs re-
sponses in acute LHON, (Nikoskelainen et al., 1977; Hrynchak and
Spafford, 1994; Mashima et al., 1997; Sharkawi et al., 2012; Ziccardi
et al., 2013). Our PR-VEP results are consistent with these previous
observations and the early involvement of the papillomacular bundle in
Fig. 5. L-cone critical flicker fusion. L-cone critical flicker frequencies (cff) were mea-
sured on a 481–nm background of 8.26 log10 quanta s−1 deg−2 and plotted as a function
of the mean log10 radiance of a 650-nm flickering target for the affected (A) and un-
affected (B) LHON carriers. The mean cff data for 15 normal observers are represented by
the grey triangles in all panels. The yellow squares (A6 F) indicate follow-up data for
Patient A6, which were obtained after spontaneous recovery of best corrected visual
acuity from 1.6 logMAR to 0.1 logMAR in the right eye. (C) Mean L-cone cff data for all
unaffected LHON carriers (yellow circles)were compared with the mean normal data
(grey triangles). The best-fitting Ferry-Porter slopes are indicated by the blue lines. The
error bars represent± 1 SEM either between runs for the individual patients or between
observers for the mean data. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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this mitochondrial optic nerve disorder. The PERG reflects central ret-
inal function and has two major components; the positive P50 and
negative N95 (Holder, 1987). The N95 component arises in RGCs
whereas approximately 30% of the P50 component originates in more
anterior retinal structures (Holder, 1987, 2001, 2004; Ryan and Arden,
1988; Viswanathan et al., 2000). P50 is widely used to assess macular
function whereas reduction in the N95:P50 ratio with preservation of
P50 amplitude or shortening of P50 peak time suggests RGC dysfunc-
tion (Holder, 2001, 2004). However, reports of PERG findings in LHON
have been contradictory (Sharkawi et al., 2012; Ziccardi et al., 2013;
Jarc-Vidmar et al., 2015). Some studies of LHON have used surface
electrodes and rapidly alternating stimuli to elicit steady-state PERG
recordings (Lam et al., 2010, 2014) but the signal:noise ratio for surface
recordings is lower than for corneal recordings and abnormal amplitude
reduction does not distinguish macular from retinal ganglion cell dys-
function. Our study found consistent PERG abnormalities with shor-
tened P50 peak time and reduced N95:P50 ratio in patients with acute
LHON. Furthermore, P50 amplitude was preserved, consistent with
adequate fixation despite the poor visual acuity and largely excluding a
macular cause for the PR-VEP abnormality.
The photopic negative response (PhNR) component of the full-field
electroretinogram is severely reduced in primates treated with te-
trodotoxin and in experimental models of glaucoma, in keeping with a
possible RGC origin (Viswanathan et al., 1999). The PhNR has also been
shown to be attenuated in experimental and clinical studies of glau-
coma and in other forms of optic neuropathies (Viswanathan et al.,
1999; Gotoh et al., 2004; Sustar et al., 2009; North et al., 2010; Preiser
et al., 2013; Machida, 2012; Morny et al., 2015). The majority of af-
fected LHON patients in our study had responses near the limits of
normal, with a substantial subgroup (40%) being within normal limits.
There is no published data describing PhNRs in LHON, but mildly ab-
normal or borderline reductions in the PhNR have similarly been re-
ported in dominant optic atrophy (Miyata et al., 2007). It is notable that
both these mitochondrial optic neuropathies predominantly affect the
papillomacular bundle with relative sparing of RGC axons in the retinal
periphery (Johnston et al., 1979; Kerrison et al., 1995; Kjer et al., 1983;
Sadun et al., 1994; Sadun et al., 2000). It should be noted that the full-
field PhNR provides a measure of global RGC function and it could
therefore be less sensitive in detecting focal RGC loss or dysfunction
compared with the pattern ERG, which arises largely in central macular
RGCs. Other methods such as focal PhNRs, involving flash stimulation
of the central macular area, could potentially offer better sensitivity
compared with full-field photopic negative responses, but with the
disadvantage of generating comparatively smaller signals. These find-
ings are pertinent to clinical trials of future therapeutic interventions,
since an undetectable VEP cannot be used to monitor safety and PERG
could prove the objective test of choice to monitor function of the most
affected RGCs.
The international standard VEP and PERG stimuli involve high
contrast checkerboard reversal stimuli that are suprathreshold, whereas
psychophysics enables measurement of detection threshold. Affected
LHON carriers in our study had impaired chromatic resolution in the
protan and deutan axes. Their achromatic spatial sensitivity was also
severely compromised. Only the two least affected patients (A7 and A9)
were capable of performing the achromatic spatial CSF measurements,
but even then, steep sensitivity losses with increasing spatial frequency
were evident. These findings are consistent with the severe loss of the
midget RGCs and the small calibre RGC axons found in post mortem
histological studies (Sadun et al., 1994; Kerrison et al., 1995; Sadun
et al., 2000). The majority of LHON patients in our study were able to
detect a flickering long-wavelength light at high luminance levels, but
with markedly reduced temporal resolution, in keeping with a severe
deficit of magnocellular function. This previously unreported observa-
tion is pathologically relevant as it implies that the loss of parasol RGC
function is also present in acute LHON, which is consistent with the
LGN pathology reported in end-stage disease (Rizzo et al., 2012). Pre-
vious studies that have assessed the koniocellular pathway in LHON
have been limited to color vision tests (Nikoskelainen et al., 1977).
Only the least severely affected patients (A7 and A9) in our study were
able to detect flickering short-wavelength light and additional tritan
deficits in the CCT tests suggested severe koniocellular involvement.
The smaller proportional loss found along the tritan axis compared with
the protan and deutan axes in the CCT test of affected LHON carriers is
of doubtful clinical significance, since the unusually close viewing
distances adopted by 5 of the observers might have selectively reduced
the tritan thresholds due to rod intrusion, retinal inhomogeneities or
scatter. In addition, melanopsin-expressing RGCs, which are relatively
preserved in LHON (Kawasaki et al., 2010; La Morgia et al., 2010), are
preferentially sensitive to short-wavelength light (Lucas et al., 2014)
and, in theory, may also contribute to blue color discrimination.
Fig. 6. Log10 L-cone temporal contrast sensitivity. Log10 L-cone TCSFs were measured using a sinusoidally-modulated 650-nm target with a time-averaged mean radiance of 10.28 log10
quanta s−1 deg−2 superimposed on a 481-nm background of 8.29 log10 quanta s−1 deg−2 plotted as a function temporal frequency (logarithmic axis) for three affected LHON carriers
(A3, A7, A9) (pink, blue and green triangles, respectively) and for the mean of 9 unaffected LHON carriers (yellow triangles). The mean TCSFs for 12 normal observers have been shown as
grey triangles. The error bars represent± 1 SEM either between runs for the individual patients or between subjects for the mean data. The mean difference in log sensitivity between
each affected or the mean of unaffected LHON carrier and normal subjects are shown in the lower part of each panel (circles). (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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Previous studies on asymptomatic LHON carriers harboring the
m.11778A > G mutation have reported subclinical visual impairment
involving both the parvocellular and the magnocellular pathways as
revealed by subtle chromatic and luminance contrast sensitivity deficits
and impaired temporal processing (Ventura et al., 2005; Sadun et al.,
2006; Ventura et al., 2007; Gualtieri et al., 2008; Mateus et al., 2015).
Our study cohort included unaffected carriers with the m.3460A > G
and m.14484T > C LHON mutations, in addition to m.11778A > G.
Our data indicate that all three common mtDNA LHON mutations sig-
nificantly impair achromatic spatial contrast sensitivity worst for higher
spatial frequencies. The chromatic thresholds along all three confusion
lines showed mild losses compared with normals highlighting dys-
function of the parvocellular pathway and confirming a previous report
using similar methods (Mateus et al., 2015). The majority of LHON
carriers also showed abnormalities of the long-wavelength temporal
visual acuity, but with relatively minimal loss on the L-cone TCSF
measurements. These parvocelluar and magnocellular related losses
were present with all three common mtDNA LHON mutations. Unlike
the long-wavelength sensitive temporal visual acuity, impairment of the
short-wavelength temporal acuity was limited to the three unrelated
unaffected carriers harboring the m.3460A > G mutation.
Fig. 7. S-cone critical flicker frequencies (cff). This parameter was measured on a 9° 620-
nm background of 11.41 log10 quanta s−1°deg−2 and plotted as a function of the time-
averaged mean log10 radiance of a 440-nm flickering target for each affected (A) and
unaffected (B) LHON carrier (colored symbols). The mean cff data for 15 normal subjects
are shown by the grey triangles in all panels. (C). Mean S-cone cff data for all unaffected
LHON carriers (yellow circles) compared with the mean normal data (grey triangle). The
best-fitting Ferry-Porter slopes are indicated by the blue lines (C). The error bars re-
present± 1 SEM either between runs for the individual patients, or between subjects for
the mean data. (For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this article.)
Fig. 8. The Trivector Cambridge Color Test. (A) Box plots of the logarithmic vector
lengths along the protan, deutan and tritan confusion lines expressed in 10−4 u′v′ units
(defined by the CIE 1976 u′v′ color space) for the affected (1, n = 8) and unaffected (2,
n = 9) LHON carriers, and for normal observers (3, n = 15), showing median, range,
inter-quartile range and outliers for all groups. (B) Changes in the vector lengths along the
protan, deutan and tritan confusion lines have been expressed as 10−4 u′v′ units for
successive measurements of 6 affected LHON carriers and plotted as a function of time
from disease onset.
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In conclusion, our study highlights the extent and severity of diffuse
and focal electrophysiological measures of RGC dysfunction in LHON.
PERG abnormalities in LHON are largely independent of age and can be
elicited in patients with severely impaired visual acuity. Furthermore,
psychophysical tests of achromatic and chromatic visual function sug-
gest severe involvement or loss of midget, parasol and bistratified RGCs.
These findings are highly relevant for the design of future clinical trials
aimed at assessing therapeutic interventions and the viability of specific
RGC subpopulations in patients affected with LHON.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.mito.2017.07.006.
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